To validate a quantitative assay to measure antibodies to the muscle-specific tyrosine kinase (MuSK) to aid in the assessment, monitoring, and management of patients with seronegative myasthenia gravis (MG).
No takes yet. Share an insight, caveat, or question.
Bastidas et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: